AZN 6-K: Fda approval
Filed with the SEC on · accession 0001654954-26-009811
AZN filed a 6-K (foreign company report) with the SEC on Nov 16, 2026. The FDA granted approval to AstraZeneca's Imfinzi (durvalumab) in combination with enfortumab vedotin as neoadjuvant treatment followed by Imfinzi monotherapy as adjuvant treatment for adult patients with muscle-invasive bladder cancer who are ineligible for or have refused cisplatin-based…
Summary of the filing
The FDA granted approval to AstraZeneca's Imfinzi (durvalumab) in combination with enfortumab vedotin as neoadjuvant treatment followed by Imfinzi monotherapy as adjuvant treatment for adult patients with muscle-invasive bladder cancer who are ineligible for or have refused cisplatin-based chemotherapy. The approval was based on VOLGA Phase III trial data showing a 49% reduction in risk of recurrence and a 42% reduction in risk of death.
Key details
✦ Ask GOAX AI about this filing — what it means for AZN, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for AZN?
Click hereFrequently asked questions
What did AZN file with the SEC on Nov 16, 2026?
AZN filed a 6-K (Fda approval). The FDA granted approval to AstraZeneca's Imfinzi (durvalumab) in combination with enfortumab vedotin as neoadjuvant treatment followed by Imfinzi monotherapy as adjuvant treatment for adult patients with muscle-invasive bladder cancer who are ineligible for or have refused cisplatin-based chemotherapy. The approval was based on VOLGA Phase III trial data showing a 49% reduction in risk of recurrence and a 42% reduction in risk of death.
What does a fda approval mean for AZN stock?
For a small biotech one drug can be most of the company’s value. Approval opens sales; a rejection (complete response letter) can delay it by years.
How do I read a 6-K?
How foreign companies listed in the US report news and events — like an 8-K for them. Look at the exhibit names: "results", "resign", "notice" tell you the topic. Many 6-Ks are routine (meeting notices); results and leadership changes matter most.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 6-K (foreign company report): How foreign companies listed in the US report news and events — like an 8-K for them.
Other AZN SEC filings
Get alerts when AZN files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days